The ketamine effect on intracranial pressure in nontraumatic neurological illness

Journal of Critical Care

Volumn 29, Issue 6, 2014, Pages 1096-1106

  Zeiler, Frederick A ^a,b   Teitelbaum, Jeanne ^b   West, Michael ^a   Gillman, Lawrence M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

ICP; Intracranial pressure; Ketamine; Neurological illness

Indexed keywords

KETAMINE; ANESTHETIC AGENT;

ANESTHESIA INDUCTION; ARTIFICIAL VENTILATION; CEREBROSPINAL FLUID; CONTINUOUS INFUSION; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INTRACRANIAL PRESSURE; NEUROLOGIC DISEASE; NONTRAUMATIC NEUROLOGICAL ILLNESS; OUTCOME ASSESSMENT; PREMEDICATION; REVIEW; SEDATION; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT DURATION; ADULT; BRAIN DISEASE; CHILD; DRUG EFFECTS; MALE;

ADULT; ANESTHETICS, DISSOCIATIVE; BRAIN DISEASES; CHILD; HUMANS; INTRACRANIAL PRESSURE; KETAMINE; MALE;

EID: 84908135729     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.05.024     Document Type: Review

References (34)

1. Aroni F., Iacovidou N., Dontas I., Pourzitaki C., Xanthos T. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J Clin Pharmacol 2009, 49:957-964.
2. Himmelseher S., Durieux M.E. Revising a dogma: ketamine for patients with neurological injury?. Anesth Analg 2005, 101:524-534.
3. Belopavlovic M., Buchthal A. Modification of ketamine-induced intracranial hypertension in neurosurgical patients by pretreatment with midazolam. Acta Anaesthesiol Scand 1982, 26:458-462.
4. Crumrine R.S., Nulsen F.E., Weiss M.H. Alterations in ventricular fluid pressure during ketamine anesthetic in hydrocephalic children. Anesthesiology 1975, 42(6):758-761.
5. Evans J., Rosen M., Weeks R.D., Wise C. Ketamine in neurosurgical procedures. Lancet 1971, 1(7688):40-41.
6. Gardner A.E., Dannemiller F.J., Dean D. Intracranial cerebrospinal fluid pressure in man during ketamine anesthesia. Anesth Analg 1972, 51(5):741-745.
7. Gibbs J.M. The effect of intravenous ketamine on cerebrospinal fluid pressure. Br J Anaesth 1972, 44:1298-1302.
8. Kaul H.L., Bhaskaran K., Saxena N., Mitra D.K. Alterations in intracranial pressure following ketamine anesthesia in hydrocephalic children. Indian J Pediatr 1984, 51:25-28.
9. List W.F., Crumrine R.S., Cascorbi H.F., Weiss M.H. Increased cerebrospinal fluid pressure after ketamine. Anesthesiology 1972, 36(1):93-94.
10. Schulte am Esch J., Pfeifer G., Thiemig I., Entzian W. The influence of intravenous anesthetic agents on primarily increased intracranial pressure. Acta Neurochir 1978, 45:15-25.
11. Shapiro H.M., Wyte S.R., Harris A.B. Ketamine anesthesia in patients with intracranial pathology. Br J Anaesth 1972, 44:1200-1204.
12. Thorsen T., Gran L. Ketamine/diazepam infusion anesthesia with special attention to the effect on cerebrospinal fluid pressure and arterial blood pressure. Acta Anaesthesiol Scand 1980, 24:1-4.
13. Wyte S.R., Shapiro H.M., Turner P., Harris A.B. Ketamine-induced intracranial hypertension. Anesthesiology 1972, 36(2):174-176.
14. Bar-Joseph G., Guilburd Y., Guilburd J. Ketamine effectively prevents intracranial pressure elevations during endotracheal suctioning and other distressing interventions in patients with severe traumatic brain injury. Crit Care Med 2009, 37(12):A1-567.
15. Bar-Joseph G., Guilburd Y., Tamir A., Guilburd J. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr 2009, 4:40-46.
16. Boirgoin A., Albanese J., Leone M., Sampol-Manos E., Viviand X., Martin C. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain injured patients. Crit Care Med 2005, 33(5):1109-1113.
17. Boirgoin A., Albanese J., Wereszczynski N., Charbit M., Vialet R., Martin C. Safety of sedation with ketamine in severe head injury patients: comparison with fentanyl. Crit Care Med 2003, 31(3):711-717.
18. Albanese J., Arnaud S., Rey M., Thomachot L., Alliez B., Martin C. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology 1997, 87:1328-1334.
19. Kolenda H., Gremmelt A., Rading S., Braun U., Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien) 1996, 138:1193-1199.
20. Schmittner M.D., Vajkoczy S.L., Horn P., et al. Effect of fentanyl and S(+)-ketamine on cerebral hemodynamics, gastrointestinal motility, and need of vasopressors in patients with intracranial pathologies a pilot study. J Neurosurg Anesthesiol 2007, 19:257-262.
21. Abdou S.A., Shehab H.A., Samir E.M. Preliminary evaluation of ketofol-based sedation for awake craniotomies. Egypt J Anaesth 2010, 26:293-297.
22. Ben Yehuda Y., Watemburg N. Ketamine increases opening cerebrospinal fluid pressure in children undergoing lumbar puncture. J Child Neurol 2006, 21:441-443.
23. Liao R., Liu J. Combined ketamine and propofol intravenous anesthesia does not increase lumbar cerebrospinal fluid pressure in patients undergoing craniotomy. Eur J Anaesthesiol 2009, 26(Suppl 45):101-102.
24. Mayberg T.S., Lam A.M., Matta B.F., Domino K.B., Winn H.R. Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy. Anesth Analg 1995, 81:84-89.
25. Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014 (in press).
26. Phillips B., Ball C., Sackett D., Straus S., Haynes B., Dawes M. Oxford Centre for Evidence-Based Medicine levels of evidence. Version 2009 [Accessed October, 2013]. http://www.cebm.net/?o=1025.
27. Guyatt G.H., Oxman A.D., Vist G., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
28. Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schünemann H.J., et al. Rating quality of evidence and strength of recommendations: what is "quality of evidence" and why is it important to clinicians?. BMJ 2008, 336(7651):995-998.
29. Schünemann H.J., Oxman A.D., Brozek J., Glasziou P., Jaeschke R., Vist G.E., et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008, 336(7653):1106-1110.
30. Guyatt G.H., Oxman A.D., Kunz R., Jaeschke R., Helfand M., Liberati A., et al. Rating quality of evidence and strength of recommendations: incorporating considerations of resources use into grading recommendations. BMJ 2008, 336(7654):1170-1173.
31. Guyatt G.H., Oxman A.D., Kunz R., Falck-Ytter Y., Vist G.E., Liberati A., et al. Rating quality of evidence and strength of recommendations: going from evidence to recommendations. BMJ 2008, 336(7652):1049-1051.
32. Jaeschke R., Guyatt G.H., Dellinger P., Schünemann H., Levy M.M., Kunz R., et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008, 337:327-330.
33. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. (Updated March 2011) http:handbook.cochrane.org. Accessed October 25, 2013.
34. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269.